Clinical Trial Update: Pramipexole and the Risk of Serious Adverse Events

View source ↗

Summary

A clinical trial update on pramipexole highlights the risk of serious adverse events in older adults with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Older Adults (65 Years and Older), Chronic Kidney Disease (CKD) | Status: COMPLETED